Acadian Asset Management
AVDL

Acadian Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Acadian Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,144
Closed -$78K – 1959
2025
Q3 		$78K Buy
+5,144
New +$66.9K ﹤0.01% 1569
2024
Q4 		– Sell
-3,639
Closed -$47K – 1645
2024
Q3 		$47K Buy
+3,639
New +$55.4K ﹤0.01% 1801
2020
Q4 		– Sell
-151,585
Closed -$764K – 2197
2020
Q3 		$764K Buy
+151,585
New +$1.1M ﹤0.01% 1001
2019
Q4 		– Sell
-8,372
Closed -$35K – 1877
2019
Q3 		$35K Sell
8,372
-205,579
-96% -$515K ﹤0.01% 1659
2019
Q2 		$620K Sell
213,951
-630,024
-75% -$1.08M ﹤0.01% 944
2019
Q1 		$1.22M Sell
843,975
-236,902
-22% -$536K 0.01% 823
2018
Q4 		$2.79M Sell
1,080,877
-39,338
-4% -$134K 0.01% 498
2018
Q3 		$4.92M Sell
1,120,215
-210,620
-16% -$1.14M 0.02% 385
2018
Q2 		$8.16M Sell
1,330,835
-317,202
-19% -$2.23M 0.04% 323
2018
Q1 		$12M Sell
1,648,037
-5,936
-0.4% -$52.2K 0.05% 279
2017
Q4 		$13.6M Sell
1,653,973
-1,300
-0.1% -$12.2K 0.06% 244
2017
Q3 		$17.4M Sell
1,655,273
-16,934
-1% -$162K 0.08% 214
2017
Q2 		$18.4M Buy
1,672,207
+147,907
+10% +$1.48M 0.08% 214
2017
Q1 		$14.8M Sell
1,524,300
-130,373
-8% -$1.3M 0.07% 235
2016
Q4 		$17.2M Hold
1,654,673
– – 0.08% 213
2016
Q3 		$20.5M Buy
1,654,673
+37,450
+2% +$489K 0.1% 182
2016
Q2 		$17.4M Buy
1,617,223
+1,141,783
+240% +$12.2M 0.09% 191
2016
Q1 		$5.25M Buy
475,440
+299,857
+171% +$2.98M 0.03% 391
2015
Q4 		$2.14M Sell
175,583
-99,644
-36% -$1.55M 0.01% 559
2015
Q3 		$4.49M Buy
+275,227
New +$6.06M 0.02% 414

Other funds holding AVDL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management's AVDL Position: Q4 2025 in Review

Acadian Asset Management sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 5,144 shares — an estimated $78K sold.

Acadian Asset Management first reported a position in AVDL in Q3 2015 and held it in 20 quarters. The position peaked at $20.5M in Q3 2016. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • Acadian Asset Management reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Acadian Asset Management sold 5,144 Avadel Pharmaceuticals shares in Q4 2025, an estimated $78K.
  • Acadian Asset Management first reported a position in Avadel Pharmaceuticals in Q3 2015 and held it in 20 quarters.
  • Acadian Asset Management's Avadel Pharmaceuticals position peaked at $20.5M in Q3 2016.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Acadian Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.